AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.10−0.01 (-0.47%)
Close on Nov 18, 2026Market cap $213.66MP/E –Yield –
AC Immune pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
AC Immune's pe ratio was 10.8× on Feb 26, 2021, against 28.3× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Feb 26, 2021 | 10.8× | +3.6 |
| 2020 | Dec 31, 2020 | 7.1× | −21.2 |
| 2017 | Feb 28, 2017 | 28.3× | −1.6 |
| 2016 | Dec 30, 2016 | 30.0× | – |
See a number that looks wrong?